AMENDED AND RESTATED INDEMNIFICATION AGREEMENTIndemnification Agreement • March 8th, 2007 • Xoma LTD /De/ • Pharmaceutical preparations
THIS AMENDED AND RESTATED INDEMNIFICATION AGREEMENT, effective as of [insert date of original agreement], is between XOMA LTD., a Bermuda company (the “Company”), and (“Officer”).
AMENDED AND RESTATED INDEMNIFICATION AGREEMENTIndemnification Agreement • March 8th, 2007 • Xoma LTD /De/ • Pharmaceutical preparations
THIS AMENDED AND RESTATED INDEMNIFICATION AGREEMENT, effective as of [insert date of original agreement], is between XOMA LTD., a Bermuda company (the “Company”), and (“Officer/Director”).
indicates that a confidential portion of the text of this agreement has been omitted. COLLABORATION AGREEMENTCollaboration Agreement • March 8th, 2007 • Xoma LTD /De/ • Pharmaceutical preparations • California
This Collaboration Agreement (this “Agreement”) is dated as of November 1, 2006 (the “Effective Date”) and is made by and between Takeda Pharmaceutical Company Limited, a Japanese corporation having offices at 1-1, Doshomachi 4-chome, Chuo-ku, Osaka 540-8645, Japan (hereinafter “Takeda”); and XOMA (US) LLC, a Delaware limited liability company having offices at 2910 Seventh Street, Berkeley, California 94710, USA (hereinafter “XOMA”). Takeda and XOMA are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
AMENDED AND RESTATED INDEMNIFICATION AGREEMENTIndemnification Agreement • March 8th, 2007 • Xoma LTD /De/ • Pharmaceutical preparations
THIS AMENDED AND RESTATED INDEMNIFICATION AGREEMENT, effective as of [insert date of original agreement], is between XOMA LTD., a Bermuda company (the “Company”), and (“Director”).
indicates that a confidential portion of the text of this agreement has been omitted. AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • March 8th, 2007 • Xoma LTD /De/ • Pharmaceutical preparations • New York
This AMENDED AND RESTATED LICENSE AGREEMENT (this “Agreement”), dated effective as of October 27, 2006 (the “Effective Date of this Agreement”), is entered into by and between XOMA Ireland Limited, a company with limited liability organized under the laws of the Republic of Ireland having offices at Shannon Airport House, Shannon, County Clare, Ireland (with its Affiliates, “XOMA”) and DYAX Corp., a corporation organized under the laws of the State of Delaware having offices at 300 Technology Square, Cambridge, Massachusetts 02139, U.S.A. (with its Affiliates, “DYAX”).
U.S. $35,000,000 LOAN AGREEMENT Dated as of November 9, 2006 between GOLDMAN SACHS SPECIALTY LENDING HOLDINGS, INC. as Lender, XOMA LTD. as Guarantor, and XOMA (US) LLC as BorrowerLoan Agreement • March 8th, 2007 • Xoma LTD /De/ • Pharmaceutical preparations • New York
This LOAN AGREEMENT is dated as of November 9, 2006, by and between Goldman Sachs Specialty Lending Holdings, Inc., a Delaware corporation (the “Lender”), as Lender, XOMA (US) LLC, a Delaware limited liability company (the “Borrower”), as Borrower, and XOMA Ltd., a Bermuda company (“XOMA”), as guarantor. The Lender, the Borrower and XOMA are hereinafter referred to collectively as the “Parties” or individually as a “Party”.
